ANAB
AnaptysBio Inc
NASDAQ: ANAB · HEALTHCARE · BIOTECHNOLOGY
$52.14
+0.06% today
Updated 2026-07-29
Market cap
$1.49B
P/E ratio
—
P/S ratio
6.41x
EPS (TTM)
$-1.02
Dividend yield
—
52W range
$11 – $72
Volume
0.7M
AnaptysBio Inc (ANAB) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$52.14
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$369.44
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.0B | $0.0B | $0.1B | $0.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -11.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.